Cargando…
Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3
Small molecules that bind the SARS-CoV-2 nonstructural protein 3 Mac1 domain in place of ADP-ribose could be useful as molecular probes or scaffolds for COVID-19 antiviral drug discovery because Mac1 has been linked to the ability of coronaviruses to evade cellular detection. A high-throughput assay...
Autores principales: | Virdi, Rajdeep S., Bavisotto, Robert V., Hopper, Nicholas C., Vuksanovic, Nemanja, Melkonian, Trevor R., Silvaggi, Nicholas R., Frick, David N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Laboratory Automation and Screening. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684785/ https://www.ncbi.nlm.nih.gov/pubmed/32981460 http://dx.doi.org/10.1177/2472555220960428 |
Ejemplares similares
-
High-Throughput Screening and Quantum Mechanics for Identifying Potent Inhibitors Against Mac1 Domain of SARS-CoV-2 Nsp3
Publicado: (2020) -
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo
por: Taha, Taha Y., et al.
Publicado: (2023) -
Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16
por: Kozielski, Frank, et al.
Publicado: (2021) -
Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus
por: Nguyen, Phuong T. V., et al.
Publicado: (2014) -
A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo
por: Taha, Taha Y., et al.
Publicado: (2023)